Last updated on June 2020

Cognitive Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Other Details:

Study visits: Screening, Day 1 (Baseline), Week 4, Week 12, Week 24, Week 48, and Week 72.

Compensation: Contact to Find out More


Find a site near you

Start Over

Bradenton Research Center

909 Hyde Street Suite 322 Bradenton, FL USA
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.